NCT00049504 Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00043979 Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas Status COMPLETED Phase PHASE2
NCT00041288 Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL Status TERMINATED Phase PHASE2
NCT00039377 Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT00038948 Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients Status COMPLETED Phase PHASE3
NCT00031824 Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease Status COMPLETED Phase PHASE3
NCT00028600 Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00028171 Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Once Daily Versus Twice Daily Dosing Status COMPLETED Phase NA
NCT00027573 Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer Status COMPLETED Phase PHASE2
NCT00025519 Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer Status WITHDRAWN Phase PHASE2
NCT00023244 Steroid Withdrawal in Pediatric Kidney Transplant Recipients Status TERMINATED Phase PHASE2
NCT00014469 Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00007787 Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants Status COMPLETED Phase NA
NCT00006747 Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00006350 Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00006042 Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE1
NCT00005113 A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant Status TERMINATED Phase PHASE3
NCT00004904 Stem Cell Transplantation in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE1
NCT00004878 Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia Status WITHDRAWN Phase PHASE2